Please login to the form below

Not currently logged in
Email:
Password:

Baraclude interim data issued by BMS

Bristol-Myers Squibb (BMS) has announced positive 48-week data from an ongoing study of chronic hepatitis B patients with decompensated cirrhosis

Bristol-Myers Squibb (BMS) has announced 48-week data from an ongoing study of chronic hepatitis B patients with decompensated cirrhosis, in which Baraclude demonstrated greater viral suppression compared to adefovir.

"This study represents an important first step in addressing an unmet medical need, as this is one of the first comparative studies to evaluate the safety and efficacy of antiviral therapy in this difficult-to-treat patient population," said Professor Hugo Cheinquer, ETV-048 study investigator and associate professor of gastroenterology and hepatology, Universidade Federal Do Rio Grande Do Sul, Brazil. "Chronic hepatitis B is a lifelong disease and these data suggest that treatment with Baraclude may offer chronic hepatitis B patients with decompensated cirrhosis a treatment option."

Decompensated cirrhosis is characterised by severe scarring of the liver caused by chronic liver inflammation, including inflammation associated with chronic hepatitis B infection. It is estimated that 15 to 25 per cent of chronic hepatitis B patients die from complications of liver disease. Currently, the median survival rate in decompensated patients is two to three years, with only 28 per cent of patients surviving for more than five years. The treatment of chronic hepatitis B patients with decompensated cirrhosis remains an area of unmet medical need, and these patients often require liver transplant.

2nd November 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics